First report of CrpP prevalence in a South American country

dc.creatorRuiz, Joaquim
dc.creatorOcampo, Karen
dc.creatorSalvador Luján, Gina
dc.creatorReyes, Yelinda V.
dc.creatorGómez, Andrea C.
dc.creatorValera Krumdieck, Carmen
dc.creatorBaca Cumpa, Ariana D.
dc.creatorSoza, Gabriela
dc.creatorPinto, Joseph A.
dc.creatorRamos Chirinos, María
dc.creatorLagos, José
dc.creatorRiveros, Maribel
dc.creatorPons, Maria J.
dc.date.accessioned2023-03-17T21:53:18Z
dc.date.accessioned2023-05-30T21:14:50Z
dc.date.available2023-03-17T21:53:18Z
dc.date.available2023-05-30T21:14:50Z
dc.date.created2023-03-17T21:53:18Z
dc.date.issued2023-01
dc.identifierNew Microbes and New Infections. 2023: 51
dc.identifier2052-2975
dc.identifierhttps://hdl.handle.net/20.500.12959/3474
dc.identifierhttps://doi.org/10.1016/j.nmni.2023.101082
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6449451
dc.description.abstractThe presence of crpP was established in 201 Pseudomonas aeruginosa isolates from 9 Peruvian hospitals. The 76.6% (154/201) of the isolates presented the crpP gene. Overall, 123/201 (61.2%) isolates were non-susceptible to ciprofloxacin. The prevalence of crpP-possessing P. aeruginosa in Peru is higher than in other geographical areas.
dc.languageeng
dc.publisherEditorial Board
dc.relationhttps://www.sciencedirect.com/science/article/pii/S205229752300001X
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCrpP
dc.subjectPhosphorylase
dc.subjectPMQR
dc.subjectQuinolone-resistance
dc.subjectTMQR
dc.subjectFosforilasa
dc.subjectResistencia a quinolonas
dc.titleFirst report of CrpP prevalence in a South American country
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución